ELIQUIS Trademark

Trademark Overview

On Tuesday, February 26, 2002, a trademark application was filed for ELIQUIS with the United States Patent and Trademark Office. The USPTO has given the ELIQUIS trademark a serial number of 76388645. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 12, 2012. This trademark is owned by Pfizer Inc.. The ELIQUIS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation for the prevention and treatment of cardiovascular disorders
eliquis

General Information

Serial Number76388645
Word MarkELIQUIS
Filing DateTuesday, February 26, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 12, 2012
Registration Number3066277
Registration DateTuesday, March 7, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 8, 2002

Trademark Statements

Goods and Servicespharmaceutical preparation for the prevention and treatment of cardiovascular disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 12, 2012
Primary Code005
First Use Anywhere DateTuesday, November 22, 2005
First Use In Commerce DateTuesday, November 22, 2005

Trademark Owner History

Party NameBRISTOL-MYERS SQUIBB COMPANY
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10154
Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, October 12, 2012CANCELLED SEC. 8 (6-YR)
Thursday, June 30, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 30, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 1, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 27, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 27, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 7, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, January 24, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, January 20, 2006ASSIGNED TO LIE
Wednesday, January 18, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 11, 2006STATEMENT OF USE PROCESSING COMPLETE
Friday, December 16, 2005USE AMENDMENT FILED
Friday, December 16, 2005TEAS STATEMENT OF USE RECEIVED
Thursday, May 26, 2005EXTENSION 5 GRANTED
Thursday, May 26, 2005EXTENSION 5 FILED
Thursday, May 26, 2005TEAS EXTENSION RECEIVED
Wednesday, December 29, 2004EXTENSION 4 GRANTED
Thursday, December 16, 2004EXTENSION 4 FILED
Thursday, December 16, 2004TEAS EXTENSION RECEIVED
Thursday, August 19, 2004CASE FILE IN TICRS
Monday, July 12, 2004EXTENSION 3 GRANTED
Thursday, June 17, 2004EXTENSION 3 FILED
Thursday, June 17, 2004TEAS EXTENSION RECEIVED
Friday, January 9, 2004EXTENSION 2 GRANTED
Wednesday, December 17, 2003EXTENSION 2 FILED
Wednesday, December 17, 2003TEAS EXTENSION RECEIVED
Wednesday, June 25, 2003EXTENSION 1 GRANTED
Wednesday, June 25, 2003EXTENSION 1 FILED
Wednesday, June 25, 2003TEAS EXTENSION RECEIVED
Tuesday, December 31, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2002PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2002NOTICE OF PUBLICATION
Friday, July 26, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 25, 2002ASSIGNED TO EXAMINER

Related Keywords

eliquis cardiovascular disorders treatment prevention preparation pharmaceutical